Top Industry News
- MHRA Register medical devices to place on the market
- FDA General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
- MHRA phase I accreditation scheme
- FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies
- EMA to address nitrosamine impurities in upcoming revision of active substances guidance
- FDA announces plans to revamp national drug code
- FDA explains the ins and outs of real-time oncology review program in new guidance
- Pakistan seeks feedback on changes to regulation of medicine import and export fees
- TGA updates nitrosamine impurity page with details of manufacturing requirements